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2135the surgeries analyzed in this comparative study were limited
in their vast majority to blade commissurotomies and that
the subsequent evolution of surgical techniques made these
comparisons obsolete (2–4). Recent data from surgical series
indicate that surgery may achieve better outcomes than
balloon valvuloplasty, but contemporary studies comparing
outcomes after surgery and interventional catheterization are
lacking (5). In our center, aortic valve disease has for many
years been subjected to both forms of therapy. We decided
to review our experience with balloon valvuloplasty and
aortic valve surgery in order to delineate their respective
outcomes in terms of survival and need for re-intervention
and ultimate valve replacement.
Methods
This study was approved by the local Human Research
Ethics Committee and the need for consent was waived
because of the retrospective nature of the study. The ﬁles of
all patients undergoing a procedure for aortic valve stenosis
before the age of 1 year in the Royal Children’s Hospital,
Melbourne, were reviewed. Between 1977 and 2009, there
were 129 patients excluding the patients with hypoplastic
left heart syndrome and borderline small left ventricles who
underwent a Norwood procedure. Additionally, 3 overseas
patients and 3 presenting with complex intra-cardiac mal-
formations were excluded limiting the cohort of the study to
123 (35 females, 88 males).
Of these, 67 were neonates (<30 days) with a median
age of 7 days (interquartile range [IQR]: 2 to 16 days) and
56 were infants (age >31 days and <365 days) with
a median age of 81 days (IQR: 50 to 135 days). The median
age at time of initial treatment was 27 days (IQR: 6 to
76 days). Of the 123 patients, 66 (53%) had isolated
congenital aortic stenosis although 57 had associated cardiac
lesions (Table 1). The morphology of the valve was
described in the operative notes in 121 patients and was
found to be unicuspid in 11 (9%), bicuspid in 90 (74%), and
tricuspid in 20 (17%).Table 1 Associated Anomalies
Noncardiac or genetic anomalies
Turner’s syndrome 3 (2)
Cardiac anomalies
Coarctation 21 (17)
Aortic arch hypoplasia 6 (5)
Sub-aortic stenosis 1 (1)
Mitral valve stenosis/regurgitation 16 (13)
Atrial septal defect 13 (11)
Ventricular septal defect 8 (7)
Tricuspid valve stenosis/regurgitation 2 (2)
Shone’s syndrome 1 (1)
Congestive heart failure 13 (10.6)
Endocardial ﬁbroelastosis 13 (10.6)
Values are n (%).Nine patients had undergone
a previous cardiac procedure:
coarctation repair (n ¼ 6), coarc-
tation and mitral valve repair (n¼
1), coarctation and aortic arch
repair (n ¼ 1), and resection of sub-aortic stenosis (n ¼ 1).
The initial aortic valve procedure consisted in a balloon
valvuloplasty in 37 patients and in a surgical procedure in
86 patients. The mean pre-procedural peak gradient was
comparable in the patients undergoing balloon dilation
(78  22 mm Hg) and surgery (69  29 mm Hg)
(p ¼ 0.097). The distribution of the procedures over the
study period is displayed in Figure 1. The median balloon
size to aortic annulus ratio was 0.95 (IQR: 0.83 to 1.07).
Surgical techniques were limited to blade commissurotomy,
resection of nodular dysplasia, and thinning of the leaﬂets
in 75 patients (Fig. 2). Eleven patients had more complex
procedures consisting in recreation of 1 commissure
(n ¼ 9) or 2 commissures (n ¼ 1) and triangular resection
of the leaﬂet free edge (n ¼ 1). The commissures were
recreated by adjunction of 2 separate patches of glutaral-
dehyde preserved autologous pericardium to the opened
area of the valve (Fig. 2).
Seventeen of the 123 patients (15%) underwent the
following concomitant 19 procedures: coarctation repair
(n ¼ 8), hypoplastic aortic arch repair (n ¼ 1), ventricular
septal defect repair (n ¼ 6), atrial septal defect repair (n ¼ 3),
and a mitral valve repair and left atrial size reduction (n ¼ 1).
Hospital mortality was deﬁned as death prior to hospital
discharge or within 30 days of the surgery. Late mortality was
deﬁned as death after discharge or more than 30 days from the
ﬁrst valve intervention. Early re-interventions were deﬁned as
any operation on a previous valve intervention or replacement
before hospital discharge and were considered separate to late
re-operations occurring after hospital discharge. Reporting of
valve-related outcomes, such as valve thrombosis and bleeding
events, were based on published guidelines (6). Follow-up
information was gathered from the hospital database or
collected from their referring cardiologists.
Statistical analysis. Statistical analysis was performed
using Stata version 11.0 (StataCorp, College Station, Texas).
Symmetric continuous variables were summarized as mean
 SD, and median (interquartile range) otherwise. Risk
factors for the following time-related outcomes were exam-
ined using Cox regression analysis: mortality, re-intervention,
valve replacement, moderate or greater restenosis or re-
intervention, moderate or greater regurgitation, and failure
of event-free long-term outcome. For all endpoints, time was
measured starting from the day of the initial procedure. For
the regurgitation endpoint, patient times were considered to
have been censored in the event of a ﬁrst re-intervention, and
similarly, all non-mortality endpoints were considered to have
been censored in the event of late death. The variables
examined are listed in Table 2. Where feasible, variables
identiﬁed by univariate analysis as the ones most likely to be
associated with the given endpoint (hazard ratio [HR]: >2.0
Figure 1 Distribution of Procedures Over the Study Period
The diagram shows the distribution of cases of aortic valve procedure performed per year in children younger than 1 year in the Royal Children’s Hospital (surgical procedures
versus balloon dilation). Balloon dilation was initiated in the early 90s and virtually abandoned in 2006.
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model.
Results
There were 4 early deaths for a hospital mortality of 3%. Of
these, 3 deaths occurred after surgery: one in the early 1980s
in a 9-day-old patient who had a good post-operative result
but who died from hyperkalemia, one in 2006 soon after
extracorporeal circulation membrane oxygenation (ECMO)
removal in an 11-day-old patient supported for 8 days, and
multi-system organ failure led to the death of a 3-month-old
patient on the 19th post-operative day. The fourth patient
died after balloon dilation as a result of meconium aspiration
and respiratory distress 31 days post-intervention. Three
patients needed a chest exploration for hemopericardium
and 3 patients developed a femoral artery thrombosis after
a balloon dilation of the aortic valve. One patient was noted
to have a right ventricular thrombus after surgery, which was
treated conservatively.
The mean follow-up in hospital survivors was 10  7
years. Only 1 patient was lost to follow-up. Concurrent
completion of follow-up was 83% (102 of 123). There were
12 late deaths (10%). Eight late deaths occurred in patients
who had initially a surgical procedure and 4 patients after an
initial balloon dilation. Late mortality occurred between
43 days to 19 years, postoperatively. The causes of death
were low output syndrome (n ¼ 2), stroke (n ¼ 1),arrhythmia (n ¼ 1), sudden unexpected death (n ¼ 2),
noncardiac (n ¼ 2), and unknown (n ¼ 4). Survival of all
patients from the time of intervention at 10 and 20 years
were, respectively, 88% (95% CI: 81% to 93%) and 80%
(95% CI: 61% to 90%) (Fig. 3). By univariable analysis, the
factors most likely to be associated with late mortality were
presence of endocardial ﬁbroelastosis (HR: 10.3; 95% CI:
3.3 to 32.0; p < 0.001), concurrent diagnosis of heart
failure (HR: 4.7; 95% CI: 1.4 to 16.0; p ¼ 0.02), and
aortic annulus size (HR: 0.6; 95% CI: 0.3 to 0.96; p ¼
0.035). A multivariable analysis to separate the effects of
these factors was not feasible because of the small number
of late deaths.
Freedom from re-intervention. Fifty-four of the 119
hospital survivors (45%) required a re-intervention. Five
patients required early re-interventions during the initial
hospital stay. From these, 4 patients were following an
unsuccessful balloon valvuloplasty that failed to decrease
the gradient and 1 patient was due to residual aortic stenosis
post-valvotomy. Four of these 5 patients ultimately required
a Ross procedure during the initial hospital stay. Forty-nine
patients underwent a re-intervention after hospital dis-
charge. Thirty-ﬁve patients had only 1 re-intervention,
11 had 2, and 3 had 3 re-interventions. Re-intervention
procedures were balloon valvuloplasty (n ¼ 12), blade
commissurotomy with leaﬂet thinning and nodular resection
(n ¼ 8), complex aortic valve repair (n ¼ 14), and Ross
procedure (n ¼ 31).
Figure 2 Surgical Techniques of Aortic Valve Repair
Techniques of surgical repair have evolved and always include an extensive
debridement of the valve by resection of all nodular dysplasia, thinning of the
leaﬂets, and recreation of an interleaﬂet triangle by resecting the ﬁbrosis immo-
bilizing the commissure. Incised portions of stenotic valves are now resuspended
with pericardial patches to avoid regurgitation.
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Figure 3 Kaplan-Meier Survival Curve of the Entire Population
Survival of the entire population undergoing an aortic valve procedure in the Royal
Children’s Hospital between 1977 and 2009. Ten-year and 20-year survival were,
respectively, 88% (95% CI: 81% to 93%) and 83% (95% CI: 71% to 90%).
JACC Vol. 62, No. 22, 2013 Siddiqui et al.
December 3, 2013:2134–40 Neonatal and Infant Congenital Aortic Stenosis
2137At the last follow-up, 14 (38%) of the 37 patients under-
going balloon valvuloplasty and 55 (64%) of the 86 patients
undergoing surgery had not required re-intervention.
Freedom from re-intervention at 5, 10, and 20 years, respec-
tively, were 70% (95%CI: 60% to 78%), 55% (95%CI: 43% to
65%), and 40% (95% CI: 28% to 52%).
Of the factors examined (Table 2), univariable analysis
identiﬁed having a balloon valvuloplasty (HR: 3.2; p< 0.001),
undergoing an initial procedure as a neonate (HR: 2.5; p ¼
0.003) (or lower age at the time of initial procedure), unicuspid
valve morphology (HR: 3.6; p ¼ 0.011), the presence of
endocardial ﬁbroelastosis (HR: 2.4; p ¼ 0.042), and the
presence of an atrial septal defect (HR: 2.0; p ¼ 0.046) as the
factors most likely to be associated with re-intervention. The
last 3 factors occurred, respectively, in 9, 11, and 12 patients
only, and therefore were not included in a multivariable
model. Of the remaining 2 factors, by multivariable analysis
both having a balloon valvuloplasty as the primary procedure
(HR: 4.0; 95% CI: 2.1 to 7.7; p < 0.001) and undergoing
initial treatment as a neonate (HR: 3.0; 95% CI: 1.6 to 5.6;
p ¼ 0.001) were predictive of re-intervention.
The median time to re-intervention was 11 months (IQR:
2 months to 5 years) after an initial balloon valvuloplasty and
5 years (IQR: 11 months to 12 years) after a surgical
procedure. Ten years after the initial procedure, freedom
from re-intervention was 27% (95% CI: 10% to 47%) afterballoon valvuloplasty and 65% (95% CI: 52% to 76%) after
surgery (Fig. 4).
Freedom from valve replacement. Thirty-ﬁve patients
underwent a valve replacement that consisted of the
Ross procedure. Univariable analysis identiﬁed having
a unicuspid valve at time of intervention (HR ¼ 11.2; 95%
CI: 3.8 to 33; p  0.001) as the most likely factor predicting
the need for valve replacement. Thirteen of the 37 patients
(35%) undergoing a balloon valvuloplasty and 22 of the
86 undergoing surgery (26%) ultimately needed a Ross
procedure. Freedom from valve replacement was 83%
Figure 4
Freedom From Re-Intervention After Balloon Dilation
Versus Surgery as a Primary Intervention
The risk of re-intervention was higher after undergoing a primary balloon dilation
than after a surgical valvuloplasty. By multivariate analysis having a balloon val-
vuloplasty as the primary procedure was the most potent predictive factor of re-
intervention (p ¼ 0.004).
Figure 5
Freedom From Re-Intervention or Signiﬁcant Reste-
nosis After Balloon Valvuloplasty Versus Surgery as
a Primary Intervention
At latest follow-up 19 of the 69 patients who did not undergo a re-intervention had
at least moderate stenosis. The risk of re-intervention or stenosis was higher after
a primary balloon dilation than after a surgical valvuloplasty. By multivariate
analysis, balloon valvuloplasty was the only independent predictive factor of either
stenosis or re-intervention (p ¼ 0.009).
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68%) at 20 years.
Valve function. The gradient through the aortic valve
decreased from 78  22 mm Hg to 40  16 mm Hg after
balloon valvuloplasty (p < 0.001) and from 69  29 mm Hg
to 30  17 mm Hg after surgery (p < 0.001). The post-
procedural decrease in the transvalvular gradient was
similar after both procedures (38 mm Hg vs. 39 mm Hg).
Freedom from signiﬁcant restenosis or re-intervention.
At latest follow-up 16 of the 69 patients who did not
undergo a re-intervention were considered by their cardiol-
ogist to suffer from at least moderate stenosis. Their mean
peak gradient was 51  14 mm Hg. Freedom from either
re-intervention or more than moderate stenosis was 39%
(95% CI: 28% to 49%) at 15 years. At latest follow-up the
gradient of those who did not undergo a re-intervention and
were considered to have less than moderate stenosis was
32  16 mm Hg.
Of the factors examined, univariate analysis identiﬁed
having a balloon valvuloplasty (HR: 2.9; p < 0.001), uni-
cuspid valve morphology (HR: 3.9; p ¼ 0.001), undergoing
initial treatment as a neonate (HR: 1.8; p ¼ 0.024) (or lower
age at initial treatment), and the presence of endocardial
ﬁbroelastosis (HR: 2.3; p ¼ 0.032) as the factors most likely
to be associated with either restenosis or re-intervention.
The second and fourth factors were omitted from the
multivariable model because of the small number of patients
having these factors. By multivariable analysis, both having
a balloon valvuloplasty (HR: 3.6; 95% CI: 2.0 to 6.4;
p < 0.001) and undergoing initial treatment as a neonate
(HR: 2.2; 95% CI: 1.3 to 3.7; p ¼ 0.003) were predictive of
restenosis or re-intervention.
Six years after the initial procedure, freedom from re-
intervention or more than moderate restenosis was 30%(95% CI: 14% to 47%) after balloon valvuloplasty and 66%
(95% CI: 54% to 76%) after surgery (Fig. 5).
Freedom from regurgitation. At latest follow-up or just
prior to ﬁrst re-intervention, 32 patients had moderate or
greater regurgitation. Of these 32 patients, 16 had moderate
regurgitation, 8 had moderate to severe regurgitation, and
8 had severe regurgitation. Of the 69 patients who had not
needed a re-intervention, 8 had moderate regurgitation.
By univariable analysis, having a unicuspid valve (HR: 8.1;
95% CI: 2.5 to 26; p < 0.001) was predictive of occurrence of
regurgitation. Freedom from signiﬁcant regurgitation was
84% (95% CI: 75% to 90%) at 5 years, 71% (95% CI: 59% to
80%) at 10 years and 57% (95% CI: 40% to 71%) at 20 years.
Event-free long-term outcome. Forty-four patients had
an event-free long-term outcome deﬁned as requiring no re-
intervention and having less than moderate stenosis and
regurgitation at latest follow-up. Ultimately, 9 of the 37
patients who underwent balloon valvuloplasty (24%) and 39
of the 86 who underwent surgery (45%) were susceptible
to have long-lasting results with no re-intervention and
less than moderate regurgitation and stenosis. The mean
follow-up of these patients was 8  7 years (median 6 years;
IQR: 2 to 17 years). By univariable analysis, unicuspid valve
morphology (HR ¼ 4.6; p < 0.001), having balloon val-
vuloplasty as the initial procedure (HR: 2.7; p < 0.001) and
undergoing initial treatment as a neonate (HR: 1.8; p ¼
0.018) (or lower age at initial treatment) were associated
with not having an event-free long-term outcome. Accord-
ing to multivariable analysis, both having a balloon valvu-
loplasty (HR: 3.2; 95% CI: 1.8 to 5.7; p < 0.001) and being
a neonate at time of initial intervention (HR: 2.2; 95% CI:
1.3 to 3.6; p ¼ 0.002) were predictive of not having an
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morphology being excluded from the model because of the
small number of patients with this factor).
Speciﬁc outcomes in neonates and infants. When
analyzed separately in neonates and infants, patients under-
going balloon valvuloplasty had a higher risk of re-
intervention than those undergoing surgery (respectively
HR: 4; p ¼ 0.001 and HR: 3.08; p ¼ 0.047). After surgery,
freedom from re-intervention at 10 years was 55% (95% CI:
37% to 70%) for neonates and 78% (95% CI: 57% to 89%)
for infants. After balloon valvuloplasty, freedom from
re-intervention at 8 years was 15% (95% CI: 1% to 44%) for
neonates and 40% (95%CI: 12% to 68%) for infants (Figs. 6A
and 6B).
Discussion
In 2001, in 1 of the very few comparative multi-centric
studies existing in the ﬁeld of congenital heart disease,
McCrindle et al. (1) compared the results of balloonA
B
Figure 6
Freedom From Re-Intervention After Balloon Valvulo-
plasty Versus Surgery as a Primary Intervention in
Neonates (<30 Days) and Infants (31 Days to 1 Year)
The comparison between balloon dilation and surgical valvuloplasty in neonates
(A) and infants (B) shows a higher risk of re-intervention in neonates. In neonates
and children, the risk of re-intervention was higher after balloon dilation than after
surgical valvuloplasty (HR: 4.00; p ¼ 0.001 and HR: 3.08; p ¼ 0.047,
respectively).valvuloplasty with surgery and found that both approaches
achieved similar outcomes in terms of survival and re-
intervention. Most centers are favoring only 1 of the 2
approaches, following the expertise developed locally and
their personal bias. The vast majority of centers (7–9) are
favoring balloon valvuloplasty at this age, likely because the
initial decision is in the hands of the cardiologists who are
the ﬁrst physicians to care for the patient and because the
expertise in balloon valvuloplasty has been easier to develop
than advanced surgical techniques.
The last 2 decades have seen an improvement of the
techniques of aortic valve repair, and the expansion of their
use in the adult population and it is possible that the surgical
procedures performed nowadays are superior than those
practiced in the past (5,10). Until recently, neonatal surgery
of the aortic valve was limited to blind transapical dilation of
the valve or simple blade commissurotomy. A third of the
patients undergoing surgery in the comparative study of
2001 underwent a transapical balloon dilation, a procedure
closer to balloon valvuloplasty than contemporary surgery
(11). Surgeons are now realizing that in order to achieve
a more durable repair it is necessary to de-bulk the leaﬂets
from all thickening and nodular dysplasia and to resuspend
with patches the incised unsupported portion of the leaﬂets.
Knowledge gained by a single center retrospective study
will always be limited by the fact that within 1 center, 1
approach will always be favored, and expertise will mainly
be developed in that area. Our team over the course of the
last 6 years has clearly favored the surgical treatment of aortic
valve disease, but for 14 years, both approaches were offered.
Because it has been unusual to offer both approaches to
patients, it was worth reviewing our experience despite the
lack of randomization in order to compare their long-term
outcomes especially in terms of reoperation rate and mode
of failure.
Survival of the entire group compares favorably to
previous results with a hospital mortality of 2% and a late
mortality close to 10%. As expected, the patients with the
most extreme form of the disease and the patients requiring
a procedure as neonates were at higher risk of mortality.
There was in our patients a striking difference between
the 2 approaches in the risk of re-intervention. Clearly,
patients necessitating an intervention earlier in life have
a higher risk of requiring re-intervention. By the end of the
second decade following the procedure, half of our patients
required a second procedure, but half of those remaining
free of re-intervention were still showing signiﬁcant aortic
valve stenosis, and were likely to require a re-intervention
in the near future. In this review of our historical experi-
ence, patients undergoing balloon valvuloplasty required
re-intervention more rapidly than those undergoing surgical
valvuloplasty. One will argue that this observed difference is
related to the poor results achieved with balloon valvulo-
plasty in our center because we were in our learning curve at
that time. The re-intervention rate after catheter interven-
tion in our center was inferior to those reported by Pedra
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years of neonates and infants undergoing surgery were still
superior to the best results reported after balloon dilation of
an entire pediatric population (8). In our center, where both
approaches were concomitantly offered over the course of
the years, and even before the present analysis was con-
ducted, there was a gradual shift in decision-making
favoring surgery over interventional catheterization.
We believe that beneﬁts of both approaches should not
only be weighed in terms of re-intervention rates, but more
importantly, in terms of the proportion of patients who may
have a subsequent surgery postponed for several decades. At
the term of our follow-up close to half of the patients who
underwent surgery were living with a non-stenotic, non-
regurgitant native valve, a much higher proportion than if
they had undergone an initial balloon valvuloplasty. We
hope that a proportion of these patients may live with their
native valve for more than 2 decades. Delaying by several
years the re-intervention is a beneﬁt that compensates for
the invasiveness of surgery. We believe that the majority of
the patients undergoing balloon valvuloplasty will ultimately
end up with a valve replacement because of the destructive
nature of balloon valvuloplasty. The majority of these
patients will end with a Ross procedure. There has been
evidence that up to a quarter of the patients may see these
autografts fail in the 2 decades following the initial Ross
procedure because of the observed dilation of the trans-
planted autograft roots (12). It is believed that root dilation
may be prevented by favoring the inclusion technique over
the root replacement or by including the autograft in
a prosthetic graft (13). Inclusion technique can only be
performed in larger roots and can only rarely be performed in
the pediatric age. We hope that postponing the Ross
procedure to the adult age will allow the use of techniques
allowing better outcomes after the Ross procedure. We
believe that after aortic valve repair, long-standing growth
of the aortic root will be observed (14) and we hope that
this growth will enable the surgeon to perform a higher
proportion of inclusion technique at a later age.
Study limitations. The main limitation of the study is its
retrospective nature. This design cannot eliminate potential
selection bias in the distribution of the patients between the
2 approaches. Additionally, the comparison between both
approaches may have been fraught by an era effect favoring
the patients undergoing surgery as in the most recent years
when progress may have still occurred with both approaches,
the vast majority of patients underwent surgery.
Conclusions
In our one center’s experience, surgical valvuloplasty
remained the best approach to treat neonates and infantswith congenital aortic stenosis. After surgery, a higher
proportion of patients remain free of re-intervention than
after interventional catheterization and the relief of their
stenosis lasts longer.
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